3.69

5.38% -0.21

After Hours: 1.96 -1.73 -46.88%

Neuroone Medical Technologies Corp (NMTC)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Neuroone Medical Technologies Corp stock is traded at $3.69, with a volume of 54,751. It is down -5.38% in the last 24 hours and down -27.79% over the past month. NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Previous Close:

$3.90

Open:

$3.9464

24h Volume:

54,751

Relative Volume:

1.42

Market Cap:

$31.81M

Revenue:

$8.72M

Net Income/Loss:

$-6.83M

P/E Ratio:

-5.9135

EPS:

-0.624

Net Cash Flow:

$-6.27M

1W Performance:

-12.35%

1M Performance:

-27.79%

6M Performance:

-3.30%

1Y Performance:

-0.16%

1-Day Range:

$3.63

$4.03

1-Week Range:

$3.63

$4.59

52-Week Range:

$3.2736

$6.96

Neuroone Medical Technologies Corp Stock (NMTC) Company Profile

Name

Neuroone Medical Technologies Corp

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

(952) 426-1383

Address

7599 ANAGRAM DR, EDEN PRAIRIE

Employee

Twitter

Next Earnings Date

2026-05-12

Latest SEC Filings

NMTC's Discussions on Twitter

Compare NMTC vs MOBBW, SHMD, GOODO, PSNYW, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NMTC	0.99	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	2.21	2.92B	0	0	0	0.00
SHMD Schmid Group N V	7.49	430.62M	52.15M	-21.46M	0	-0.4675
GOODO Gladstone Commercial Corporation	20.20	372.90M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	3.12	290.00M	2.07B	-1.42B	-1.37B	-0.6765
DWLD Davis Select Worldwide ETF	46.89	0	0	0	0	0.00

Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-05-25	Initiated	Ladenburg Thalmann	Buy
Mar-29-22	Downgrade	Craig Hallum	Buy → Hold

Neuroone Medical Technologies Corp Stock (NMTC) Latest News

May 23, 2026

NeuroOne Medical Technologies to Restate Q1 2026 Financials After Revenue Overstatement; Reaffirms $10.5M FY2026 Guidance - Minichart

May 23, 2026

May 22, 2026

According to documents submitted by NEUROONE MEDICAL TECH to the U.S. Securities and Exchange Commission, the company has restated its financial data for the first quarter of 2026 to correct a previous overstatement of revenue by approximately $50 - Bitget

May 22, 2026

NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 - Scott Coop

May 22, 2026

NeuroOne (Nasdaq: NMTC) to restate March 31 2026 results, keeps guidance - Stock Titan

May 22, 2026

May 18, 2026

Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises By Investing.com - Investing.com South Africa

May 18, 2026

Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises - Investing.com

May 18, 2026

May 14, 2026

Maxim Group Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $13 - Moomoo

May 14, 2026

May 13, 2026

NMTC Maintains Buy Rating by Ladenburg Thalmann -- Price Target Raised to $8.80 - GuruFocus

May 13, 2026

NeuroOne Medical Tech Price Target Raised to $8.00/Share From $1.60 by Ladenburg Thalmann - Moomoo

May 13, 2026

NeuroOne Medical Tech Q2 2026 Earnings Call Transcript - Sahm

May 13, 2026

NeuroOne Medical (NMTC) Price Target Raised to $8 - GuruFocus

May 13, 2026

Ladenburg Thalmann Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Cuts Target Price to $8 - Moomoo

May 13, 2026

May 12, 2026